Tumor cell dormancy is sustained by a variety of factors and is characterized by elevated levels of the cyclin-dependent kinase inhibitor p27, which inhibits progression from G0 to G1 and from G1 to S phase of the cell cycle [8, 9]. Here, CDKN1B is linked to neoplasm.